Filing metadata

Accession number
0001600620-23-000041
Form type
Form 3
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Sep 22, 2023
Reporting period
Sep 21, 2023
Description
Initial ownership

Explore SEC Filings Hub